Optical resolution of baclofen via diastereomeric salt pair formation between 3-(p-chlorophenyl)glutaramic acid and (S)-(-)-α-phenylethylamine

(Note: The full text of this document is currently only available in the PDF Version )

Mino R. Caira, Rainer Clauss, Luigi R. Nassimbeni, Janet L. Scott and Alexander F. Wildervanck


Abstract

The structures of the diastereomeric salts of (R)-(+)- and (S)-(-)-3-(p -chlorophenyl)glutaramic acid with (S)-(-)-phenylethylamine have been determined by X-ray crystallography. Solubility and melting behaviours of the salts were analysed and correlated with their structural properties in the solid state. The (R)-(+)-3-(p-chlorophenyl)glutaramic acid was converted to (R)-(-)-baclofen via a Hofmann degradation (57% yield, 99.8% ee, enantiomeric excess).


References

  1. K. Rudnick and K. Bochow, Ger. Pat. DD 234 162, 1986 Search PubMed; Chem. Abstr. 1987, 106, 4530c Search PubMed.
  2. P. Hudgson and D. Weightman, Brit. Med. J., 1971, 4, 15 Search PubMed.
  3. H. R. Olpe, H. Demiéville, V. Baltzer, W. L. Benzce, W. P. Koella, P. Wolf and H. L. Haas, Eur. J. Pharmacol., 1978, 52, 133 CrossRef CAS.
  4. C. H. Chang, D. S. C. Yang, C. Y. Chung, W. Bi-Cheng, J. Pletcher, M. Sax and C. F. Terrence, Acta Crystallogr., Sect. B, 1982, 38, 2065 CrossRef.
  5. (a) E. W. Wuis, E. W. J. Beneken Kolmer, L. E. C. van Beijsterveld, R. C. M. Burgers, T. B. Vree and E. v. d. Kleyn, J. Chromatogr., 1987, 451, 419; (b) C. Vaccher, P. Berthelot and M. Debaert, J. Chromatogr., 1993, 45, 95 CrossRef CAS; (c) A. Sano, S. Takitani and H. Nakamura, Kuromatogurafi, 1994, 15(4), 234 Search PubMed.
  6. (a) C. Herdies and H. P. Hubmann, Tetrahedron Asymmetry, 1992, 3(9), 1213 CrossRef CAS; (b) A. Shoenfelder, A. Mann and S. Le Coz, Synlett, 1993, 1, 63 CrossRef; (c) S. Yoshifuji and M. Kaname, Chem. Pharm. Bull., 1995, 43, 1302 CAS.
  7. R. Chênevert and M. Desjardins, Can. J. Chem., 1994, 72, 2312 CAS.
  8. Chirality in Industry. A. N. Collins, G. N. Sheldrake and J. Crosby, ed., Wiley, London, 1992, p. 20 Search PubMed.
  9. M. Sobocinska, G. Kupryszewski and M. M. Zobaczewa, Rocz. Chem., 1974, 48, 461 Search PubMed.
  10. N. A. Sivov, R. A. Gracheva, V. M. Potapov, L. G. Polevoi and I. P. Neumyvakin, Otkrytiya, Izobret., Prom. Obraztsy, Tovarnye Znaki, 1981, 17, 88[Pat. USSR827480/7 May ( 1981)] Search PubMed.
  11. F. Morlacchi, V. Losacco and V. Tortorella, Gazz. Chim. Ital., 1975, 105, 349 CAS.
  12. See for example: (a) R. Yoshioka, O. Ohtsuki, T. Da-Ta, K. Okamura and M. Senuma, Bull. Chem. Soc. Jpn., 1994, 67, 3012 CAS; (b) F. J. J. Leusen, H. J. Bruins Slot, J. H. Noordijk, A. D. van der Haest, H. Wynberg and A. Bruggink, Recl. Trav. Chim. Pays-Bas, 1992, 111, 111 CAS; (c) M. Czugler, I. Csöregh, A. Kálmán, F. Faigl and M. Ács, J. Mol. Struct., 1989, 196, 157 CrossRef CAS.
  13. K. Yvon, W. Jeitschko and E. J. Parthé, J. Appl. Crystallogr., 1977, 10, 73 CrossRef.
  14. A. C. T. North, D. C. Philips and F. S. Matthews, Acta Crystallogr., Sect. A, 1968, 24, 351 CrossRef.
  15. G. M. Sheldrick, SHELX-86, in Crystallographic computing 3, eds. G. M. Sheldrick, C. Kruger and R. Goddard, Oxford University Press, Oxford, 1985, p. 175 Search PubMed.
  16. G. M. Sheldrick, SHELX-93: A program for Crystal Structure Determination, J. Appl. Crystallogr., in preparation, 1993 Search PubMed.
  17. H. D. Flack and D. Swarzenbach, Acta Crystallogr., Sect. A, 1988, 44, 499 CrossRef.
  18. D. Kozma, G. Pokol and M. Ács, J. Chem. Soc., Perkin Trans. 2, 1992, 435 RSC.
  19. E. Fogassy, A. Lopata, F. Faigl, F. Darvas and M. Ács, Tetrahedron Lett., 1980, 21, 647 CrossRef CAS.
  20. R. Taylor, O. Kennard and W. Versichel, Acta Crystallogr., Sect. B, 1984, 40, 280 CrossRef.
  21. P. Murray-Rust and T. Glusker, J. Am. Chem. Soc., 1984, 106, 1018 CrossRef CAS.
  22. A. Vedani and J. D. Dunitz, J. Am. Chem. Soc., 1985, 107, 7653 CrossRef CAS.
  23. F. Toda, Supramolecular Chemistry, 1995, 6, 159 CrossRef CAS.
  24. M. Ács, Acta Chim. Hung.—Models in Chemistry, 1995, 132, 409 Search PubMed.
Click here to see how this site uses Cookies. View our privacy policy here.